Bayer Aktiengesellschaft (BAYRY)
- Previous Close
7.26 - Open
7.39 - Bid --
- Ask --
- Day's Range
7.24 - 7.39 - 52 Week Range
6.96 - 16.47 - Volume
109,141 - Avg. Volume
2,073,077 - Market Cap (intraday)
28.451B - Beta (5Y Monthly) 0.97
- PE Ratio (TTM)
-- - EPS (TTM)
-0.80 - Earnings Date --
- Forward Dividend & Yield 0.03 (0.41%)
- Ex-Dividend Date Apr 29, 2024
- 1y Target Est
28.89
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
www.bayer.com96,931
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BAYRY
Performance Overview: BAYRY
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BAYRY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BAYRY
Valuation Measures
Market Cap
28.36B
Enterprise Value
62.91B
Trailing P/E
--
Forward P/E
5.22
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.56
Price/Book (mrq)
0.81
Enterprise Value/Revenue
1.32
Enterprise Value/EBITDA
6.02
Financial Highlights
Profitability and Income Statement
Profit Margin
-6.17%
Return on Assets (ttm)
4.04%
Return on Equity (ttm)
-8.17%
Revenue (ttm)
47.64B
Net Income Avi to Common (ttm)
-2.94B
Diluted EPS (ttm)
-0.80
Balance Sheet and Cash Flow
Total Cash (mrq)
10.59B
Total Debt/Equity (mrq)
136.06%
Levered Free Cash Flow (ttm)
1.52B
Research Analysis: BAYRY
Company Insights: BAYRY
BAYRY does not have Company Insights
Research Reports: BAYRY
Analyst Report: Bayer Aktiengesellschaft
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.
RatingPrice TargetAnalyst Report: Bayer Aktiengesellschaft
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.
RatingPrice TargetAnalyst Report: Bayer Aktiengesellschaft
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.
RatingPrice TargetAnalyst Report: Bayer Aktiengesellschaft
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.
RatingPrice Target